The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Open accessAbstract
Mitochondrial dysfunction is a prominent feature of Alzheimer's disease (AD) neurons. In this study, we explored the involvement of an abnormal mitochondrial dynamics by investigating the changes in the expression of mitochondrial fission and fusion proteins in AD brain and the potential cause and consequence of these changes in neuronal cells. We found that mitochondria were redistributed away from axons in the pyramidal neurons of AD brain. Immunoblot analysis revealed that levels of DLP1 (also referred to as Drp1), OPA1, Mfn1, and Mfn2 were significantly reduced whereas levels of Fis1 were significantly increased in AD. Despite their differential effects on mitochondrial morphology, manipulations of these mitochondrial fission and fusion proteins in neuronal cells to mimic their expressional changes in AD caused a similar abnormal mitochondrial distribution pattern, such that mitochondrial density was reduced in the cell periphery of M17 cells or neuronal process of primary neurons and correlated with reduced spine density in the neurite. Interestingly, oligomeric amyloid-beta-derived diffusible ligands (ADDLs) caused mitochondrial fragmentation and reduced mitochondrial density in neuronal processes. More importantly, ADDL-induced synaptic change (i.e., loss of dendritic spine and postsynaptic density protein 95 puncta) correlated with abnormal mitochondrial distribution. DLP1 overexpression, likely through repopulation of neuronal processes with mitochondria, prevented ADDL-induced synaptic loss, suggesting that abnormal mitochondrial dynamics plays an important role in ADDL-induced synaptic abnormalities. Based on these findings, we suggest that an altered balance in mitochondrial fission and fusion is likely an important mechanism leading to mitochondrial and neuronal dysfunction in AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased accumulation of APP and its processed peptides in the mitochondria of AD neurons and their effects on mitochondrial dynamics and mitophagy have been documented (21–24).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial fission-fusion dynamics through alterations of Drp1, Parkin, and Pink1 functions (23,24), which play essential roles in mitophagy induction and mitochondrial quality control during healthy brain aging, are disrupted in various neurodegenerative diseases, including Parkinson’s disease (PD) and AD (25).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [24]
In the citing paper
“Aβ accumulates in mitochondria in AD brain, which is accompanied by altered mitochondrial structure, decreased mitochondrial respiratory function and ATP production, impaired mitochondrial dynamics, and elevated mitochondria-associated oxidative stress.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Mitochondrial Aβ levels correlate with abnormalities in mitochondrial structure and function.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Aβ peptides can induce ROS production from mitochondria, leading to release of cytochrome c and apoptosis-inducing factor, thereby driving mitochondrial dysfunction, cell apoptosis and neuronal loss [97, 100].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Soluble Aβ oligomers disrupted the balance between mitochondrial fission and fusion, leading to significant mitochondrial dysfunction.197,198”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Dynamin-related Protein Drp1 Is Required for Mitochondrial Division in Mammalian Cells
Smirnova, E., Griparić, L., Shurland, D., & van der Bliek, A. M. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2245 · Cited by 1,938
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses
Li, Z., Okamoto, K.-I., Hayashi, Y., & Sheng, M. (2004) · Cell · doi:10.1016/j.cell.2004.11.003 · Cited by 1,498
Cited by
Sorted by citations
Items 701–800 of 1,001
Koo, J., & Kang, E. (2019) · Physical Activity and Nutrition · doi:10.20463/jenb.2019.0005 · Cited by 26
Poejo, J., Salazar, J., Mata, A. M., & Gutiérrez‐Merino, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094976 · Cited by 28
Yu, H., Zhu, Y., Zhang, X.-L., Wang, L., Yan-meng, Z., Zhang, F.-F., Zhang, H., & Zhao, X. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06076-x · Cited by 26
Mitofusin-2: Functional switch between mitochondrial function and neurodegeneration
Kulkarni, P. G., Mohire, V. M., Bhaisa, P. K., Joshi, M., Puranik, C. M., Waghmare, P. P., & Banerjee, T. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.02.001 · Cited by 27
Kathuria, A., Lopez-Lengowski, K., Watmuff, B., & Karmacharya, R. (2023) · Genome Medicine · doi:10.1186/s13073-023-01203-5 · Cited by 24
Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease
Reddy, A. P., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.010 · Cited by 25
Ablation of dynamin-related protein 1 promotes diabetes-induced synaptic injury in the hippocampus
Park, K. A., Lee, J. Y., Han, H. M., An, H. S., Jin, Z. H., Jeong, E. A., Kim, K. E., Shin, H. J., Lee, J., Kang, D., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03723-7 · Cited by 27
RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
Awasthi, S., Hindle, A., Sawant, N. A., George, M., Vijayan, M., Kshirsagar, S., Morton, H., Bunquin, L. E., Palade, P., Lawrence, J. J., et al. (2021) · Cells · doi:10.3390/cells10113113 · Cited by 25
Ebselen Interferes with Alzheimer’s Disease by Regulating Mitochondrial Function
Li, X., Shi, Q., Xu, H., Xiong, Y., Wang, C., Le, L., Lian, J., Wu, G., Peng, F., Liu, Q., et al. (2022) · Antioxidants · doi:10.3390/antiox11071350 · Cited by 25
Self-citationMolecular understanding of ER-MT communication dysfunction during neurodegeneration
Sammeta, S. S., Banarase, T. A., Rahangdale, S. R., Wankhede, N. L., Aglawe, M. M., Taksande, B. G., Mangrulkar, S. V., Upaganlawar, A. B., Koppula, S., Kopalli, S. R., et al. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.07.005 · Cited by 26
Volloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512246 · Cited by 29
Do we age because we have mitochondria?
Bereiter‐Hahn, J. (2013) · PROTOPLASMA · doi:10.1007/s00709-013-0515-x · Cited by 25
Ruíz, M., Bégou, M., Launay, N., Ranea‐Robles, P., Bianchi, P., López‐Erauskin, J., Morató, L., Guilera, C., Petit, B., Vaurs‐Barrière, C., et al. (2017) · Brain Pathology · doi:10.1111/bpa.12571 · Cited by 25
Pradeepkiran, J. A., Reddy, A. P., Yin, X., Mańczak, M., & Reddy, P. H. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz227 · Cited by 25
Calcium channel blockers and Alzheimer's disease.
Tan, Y., Deng, Y., & Qing, H. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.02.010 · Cited by 23
Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism
Cho, S., Lee, H., & Seo, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02297-x · Cited by 25
Self-citationMitofusin 2 displays fusion-independent roles in proteostasis surveillance
Joaquim, M., Altin, S., Bulimaga, M.-B., Simões, T., Nolte, H., Bader, V., Franchino, C. A., Plouzennec, S., Szczepanowska, K., Marchesan, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56673-5 · Cited by 24
Targeting Mitophagy in Alzheimer’s Disease
Jayatunga, D. P. W., Hone, E., Bharadwaj, P., Garg, M. L., Verdile, G., Guillemin, G. J., & Martins, R. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191258 · Cited by 25
Wang, S., Ichinomiya, T., Terada, Y., Wang, D., Patel, H. H., & Head, B. P. (2021) · Cells · doi:10.3390/cells10092487 · Cited by 24
Chen, F., Bai, J., Zhong, S., Zhang, R., Zhang, X., Xu, Y., Zhao, M., Zhao, C., & Zhou, Z. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9565545 · Cited by 24
Maneechote, C., Chunchai, T., Apaijai, N., Chattipakorn, N., & Chattipakorn, S. C. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02813-7 · Cited by 24
Role of Mitophagy in neurodegenerative Diseases and potential tagarts for Therapy
Jiao, L., Du, X., Li, Y. H., Jiao, Q., & Jiang, H. F. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07738-x · Cited by 24
Bezafibrate confers neuroprotection in the 5xFAD mouse model of Alzheimer's disease
Lu, Y., Fujioka, H., Wang, W., & Zhu, X. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166841 · Cited by 27
Self-citationCalcium signals tune AMPK activity and mitochondrial homeostasis in dendrites of developing neurons
Hatsuda, A., Kurisu, J., Fujishima, K., Kawaguchi, A., Ohno, N., & Kengaku, M. (2023) · Development · doi:10.1242/dev.201930 · Cited by 25
Mailänder, V., Tomcin, S., Baier, G., & Landfester, K. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s70908 · Cited by 24
Kim, Y. J., Park, J. K., Kang, W. S., Kim, S. K., Han, C., Na, H. R., Park, H. J., Kim, J.-W., Kim, Y. Y., Park, M. H., et al. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.1.81 · Cited by 25
Iron‐induced energy supply deficiency and mitochondrial fragmentation in neurons
Huang, X. T., Liu, X., Ye, C. Y., Tao, L.-X., Zhou, H., & Zhang, H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14621 · Cited by 26
Villamil-Ortiz, J. G., Barrera-Ocampo, A., Arias-Londoño, J. D., Villegas, A., Lopera, F., & Cardona-Gómez, G. P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170554 · Cited by 24
Khan, S., Bano, N., Ahamad, S., John, U., Dar, N. J., & Bhat, S. A. (2024) · Aging and Disease · doi:10.14336/ad.2024.0125-1 · Cited by 27
Ansoleaga, B., Garcia‐Esparcia, P., Llorens, F., Hernández‐Ortega, K., Carmona, M., del Rı́o, J. A., Zerr, I., & Ferrer, I. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw048 · Cited by 23
Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations
Mani, S., Swargiary, G., Singh, M., Agarwal, S., Dey, A., Ojha, S. K., & Jha, N. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119985 · Cited by 24
Site-specific mitochondrial dysfunction in neurodegeneration
Vodičková, A., Koren, S. A., & Wojtovich, A. P. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.02.004 · Cited by 22
Age-Dependent Behavioral and Metabolic Assessment of AppNL−G−F/NL−G−F Knock-in (KI) Mice
Wang, S., Ichinomiya, T., Savchenko, P., Devulapalli, S., Wang, D., Beltz, G., Saito, T., Saido, T. C., Wagner, S. L., Patel, H. H., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.909989 · Cited by 23
Exercise and mitochondrial remodeling to prevent age-related neurodegeneration
O’Reilly, C. L., Miller, B. F., & Lewis, T. L. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00611.2022 · Cited by 25
Lauritzen, K. H., Chang, C. K., Wiksen, H., Bergersen, L. H., & Klungland, A. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.04.011 · Cited by 23
Kumar, A., John, L., Maity, S., Manchanda, M., Sharma, A., Saini, N., Chakraborty, K., & Sengupta, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228072 · Cited by 23
Gray, J. J., Zommer, A. E., Bouchard, R. J., Duval, N., Blackstone, C. D., & Linseman, D. A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.12.001 · Cited by 23
Relationship Between β-Amyloid and Mitochondrial Dynamics
Kim, D. I., Lee, K. H., Oh, J. Y., Kim, J. S., & Han, H. J. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0434-4 · Cited by 23
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1007 · Cited by 23
Correia, S. C., Machado, N. J., Alves, M. G., Oliveira, P. F., & Moreira, P. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010461 · Cited by 25
Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer’s Disease
Adiele, R. C., & Adiele, C. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150967 · Cited by 23
The challenges of axon survival: Introduction to the special issue on axonal degeneration
Coleman, M. P. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.06.007 · Cited by 22
O’Shea, R. D., Lau, C. L., Zulaziz, N., Maclean, F. L., Nisbet, D. R., Horne, M. K., & Beart, P. M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00050 · Cited by 23
Bevan, R. J., Williams, P. A., Waters, C. T., Thirgood, R. A., Mui, A., Seto, S., Good, M. A., Morgan, J. E., Votruba, M., & Erchova, I. A. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa101 · Cited by 22
Kim, S. Y., Strucinska, K., Osei, B., Han, K., Kwon, S., & Lewis, T. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1042616 · Cited by 21
The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220079 · Cited by 22
Olesen, M. A., & Quintanilla, R. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03434-4 · Cited by 23
H2S releasing aspirin protects amyloid beta induced cell toxicity in BV-2 microglial cells
Liu, Y.-Y., Sparatore, A., Soldato, P. D., & Bian, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.023 · Cited by 22
Alterations in mitochondrial number and function in Alzheimer’s disease fibroblasts
Gray, N. E., & Quinn, J. F. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9667-z · Cited by 21
Su, K., BOURDETTE, D. N., & Forte, M. A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00285 · Cited by 22
Giese, K.-P. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00036 · Cited by 22
Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration
Dar, K. B., Bhat, A. H., Amin, S., Reshi, B. A., Zargar, M. A., Masood, A., & Ganie, S. A. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00741-0 · Cited by 23
Back to The Fusion: Mitofusin-2 in Alzheimer’s Disease
Sita, G., Hrelia, P., Graziosi, A., & Morroni, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010126 · Cited by 24
Hosseini, L., Mahmoudi, J., Pashazadeh, F., Salehi‐Pourmehr, H., & Sadigh‐Eteghad, S. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01842-6 · Cited by 23
Kwon, B., Gamache, T., Lee, H., & Querfurth, H. W. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.012 · Cited by 23
Self-citationIntraneuronal β-amyloid impaired mitochondrial proteostasis through the impact on LONP1
Wang, W., Ma, X., Bhatta, S., Shao, C., Zhao, F., Fujioka, H., Torres, S. L., Wu, F., & Zhu, X. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316823120 · Cited by 22
Self-citationImpact of diet and exercise on mitochondrial quality and mitophagy in Alzheimer's disease
Pradeepkiran, J. A., Islam, M. A., Sehar, U., Reddy, A. P., Vijayan, M., & Reddy, P. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102734 · Cited by 25
Zhao, B., Wei, D., Long, Q., Chen, Q., Wang, F., Chen, L., Li, Z., Li, T., Ma, T., Liu, W., et al. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.10.006 · Cited by 21
D. melanogaster, mitochondria and neurodegeneration: small model organism, big discoveries
Debattisti, V., & Scorrano, L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.007 · Cited by 21
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
Hoekstra, J. G., Montine, K. S., Zhang, J., & Montine, T. J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt83 · Cited by 21
Fessel, W. J. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517698790 · Cited by 21
Tamada, H., Kiryu‐Seo, S., Hosokawa, H., Ohta, K., Ishihara, N., Nomura, M., Mihara, K., Nakamura, K., & Kiyama, H. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24213 · Cited by 21
He, Y.-C., Kong, F., Fan, L.-Y., Wu, J. Y., Liu, X.-P., Li, J., Sun, Y., Zhang, Q., Yang, Y., Wu, X.-J., et al. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.06.007 · Cited by 21
An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
Marcelli, S., Ficulle, E., Piccolo, L., Corbo, M., & Feligioni, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.023 · Cited by 21
Mitochondrial Miro GTPases coordinate mitochondrial and peroxisomal dynamics
Zinsmaier, K. E. (2020) · Small GTPases · doi:10.1080/21541248.2020.1843957 · Cited by 22
Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1
Arif, T., Shteinfer‐Kuzmine, A., & Shoshan‐Barmatz, V. (2024) · Biomolecules · doi:10.3390/biom14101304 · Cited by 23
Mitochondrial Alterations in Alzheimer’s Disease: Insight from the 5xFAD Mouse Model
Keskinöz, E. N., Çelik, M., Toklucu, E. S., Birisik, K., Erişir, A., & Arslan, D. Ö. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04632-4 · Cited by 21
Mitochondrial fission and fusion in neurodegenerative diseases:Ca2+ signalling
Liu, X., Li, T., Tu, X., Xu, M., & Wang, J. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.103992 · Cited by 22
Advances in Sequencing Technologies for Understanding Hereditary Ataxias
Didonna, A., & Opal, P. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3097 · Cited by 20
D’Errico, M., Parlanti, E., Pascucci, B., Filomeni, G., Mastroberardino, P. G., & Dogliotti, E. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108977 · Cited by 20
Houle, S., & Kokiko‐Cochran, O. N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.788055 · Cited by 22
Mitophagy: An Emergence of New Player in Alzheimer’s Disease
Sharma, B., Pal, D., Sharma, U., & Kumar, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.921908 · Cited by 21
Tan, Y., Tang, W., Xiao, W., Huang, R., Li, X., Peng, W., Yan, K., Cao, Y., Zeng, Y., & Kang, J. M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1105690 · Cited by 22
Self-citationMohanad, M., Mohamed, S. K., Aboulhoda, B. E., & Ahmed, M. A. E. (2023) · BioFactors · doi:10.1002/biof.2013 · Cited by 23
Han, X., HUANG, S. H., Zhuang, Z., Zhang, X., Xie, M., Lou, N.-J., Hua, M., Zhuang, X., Yu, S., & Chen, S. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102996 · Cited by 20
Xiao, A., Gan, X., Chen, R., Ren, Y., Yu, H., & You, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.068 · Cited by 20
Physical exercise mitigates behavioral impairments in a rat model of sporadic Alzheimer’s disease
Bernardo, T. C., Beleza, J., Rizo‐Roca, D., Alves, E. S., Leal, C., Martins, M. J., Ascensão, A. A. M. R., & Magalhães, J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112358 · Cited by 22
Cheng, Y., Buchan, M. J., Vitanova, K. S., Aitken, L., Gunn‐Moore, F. J., Ramsay, R. R., & Doherty, G. H. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15003 · Cited by 21
Li, L., Kim, H. J., Roh, J. H., Kim, M., Koh, W., Kim, Y., Heo, H., Chung, J. H., Nakanishi, M., Yoon, T., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12798 · Cited by 19
Diling, C., Yong, T., Jian, Y., Chaoqun, Z., Shuai, O., & Yizhen, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00219 · Cited by 21
Plasmid-driven RNA interference in fish cell lines
Collet, B., Collins, C., Cheyne, V., & Lester, K. (2022) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-022-00645-2 · Cited by 19
Liu, X., Li, Y., Wang, J., Meng, T., Song, L., Yang, L., Yu, J., & Ma, C. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01601-1 · Cited by 19
Panchal, K., & Tiwari, A. K. (2020) · Biology Open · doi:10.1242/bio.049569 · Cited by 21
Tan, Z., Zhao, M., Li, J., Li, S., Zhu, S., Yao, X., Gao, X., & Yang, S. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-377 · Cited by 20
Salman, M., Akram, M. V., Shahrukh, M., Ishrat, T., & Parvez, S. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.07.006 · Cited by 19
Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms
Karbowski, M., Oshima, Y., & Verhoeven, N. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04604-8 · Cited by 21
Mishra, E., & Thakur, M. K. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03397-6 · Cited by 19
Mitochondrion-based organellar therapies for central nervous system diseases
Zhao, M., Wang, J., Zhu, S., Wang, M., Chen, C., Wang, L., & Liu, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01843-z · Cited by 21
Trends in Mitochondrial Therapeutics for Neurological Disease
Leitão-Rocha, A., Guedes-Dias, P., Pinho, B. R., & Oliveira, J. M. A. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209160317 · Cited by 19
Mitochondrial quality control and neurodegenerative diseases
Gao, F., & Zhang, J. (2018) · Neuronal Signaling · doi:10.1042/ns20180062 · Cited by 19
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1006 · Cited by 19
The ubiquitous role of mitochondria in Parkinson and other neurodegenerative diseases
Theocharopoulou, G. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2020004 · Cited by 19
Mitochondria, Diabetes, and Alzheimer’s Disease
Milone, M. (2012) · Diabetes · doi:10.2337/db12-0209 · Cited by 19
Almaguer, J., Hindle, A., & Lawrence, J. J. (2023) · Antioxidants · doi:10.3390/antiox12111921 · Cited by 19
Kostrzewska, P., Kuca, P., Witek, P., Małyszko, J., Madetko‐Alster, N., & Alster, P. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00832-9 · Cited by 20
Mitochondrial DNA: a molecular switch driving sterile neuroinflammation
Jauhari, A., Singh, T., Carlisle, D. L., & Friedlander, R. M. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00540-w · Cited by 20
Castora, F. J., Kerns, K. A., Pflanzer, H. K., Hitefield, N. L., Gershon, B. S., Shugoll, J., Shelton, M. G., & Coleman, R. A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220161 · Cited by 18
Porcine aminopeptidase N binds to F4+ enterotoxigenic Escherichia coli fimbriae
Xia, P., Wang, Y., Zhu, C., Zou, Y., Yang, Y., Liu, W., Hardwidge, P. R., & Zhu, G. (2016) · Veterinary Research · doi:10.1186/s13567-016-0313-5 · Cited by 18
Liu, X., Zhang, Y., Ji, S., Zhao, L., Shang, W., Li, D., Chen, Z., Tong, C., & Fan, H. (2017) · Endocrinology · doi:10.1210/en.2017-00487 · Cited by 18
Are Sigma Receptor Modulators a Weapon Against Multiple Sclerosis Disease?
Collina, S., Rui, M., Stotani, S., Bignardi, E., Rossi, D., Curti, D., Giordanetto, F., Malacrida, A., Scuteri, A., & Cavaletti, G. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0122 · Cited by 17
Metadata
- Authors
- Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X.
- Affiliations
- Case Western Reserve University (US)
- The University of Texas at San Antonio (US)
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-07-15
- Volume
- 29
- Issue
- 28
- Pages
- 9090-9103
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2735241
- OpenAlex
- W2089141103
- Cited by
- 1,224
- References
- 50
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 71 · 2023: 92 · 2022: 77 · 2021: 102 · 2020: 83 · 2019: 71 · 2018: 60 · 2017: 75 · 2016: 67 · 2015: 59 · 2014: 57 · 2013: 58 · 2012: 84
- FWCI
- 29.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association (AG031852, IIRG-07-60196)
- National Institutes of Health (IIRG-07-60196)
- National Institute on Aging (AG 031852, R01AG031852)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Alzheimer's disease, mitochondrial dynamics, mitochondrial fission, mitochondrial fusion, Drp1, OPA1, Mfn1, mitofusin 2, Fis1, mitochondrial distribution, axons, pyramidal neurons, synaptic loss, dendritic spines, PSD-95, mitochondrial dysfunction
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Animals, Antibodies, Monoclonal, Biotin, Cells, Cultured, Embryo, Mammalian, Gene Expression Regulation, Hippocampus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Middle Aged, Mitochondria, Mutation, Neuroblastoma, Neurons, Postmortem Changes, Time Factors, Transfection, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, GTP Phosphohydrolases, Mitochondrial Proteins, Membrane Transport Proteins, Mitochondrial Membrane Transport Proteins, Dynamins, Green Fluorescent Proteins, Rats, Cyclooxygenase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
